Merck and Moderna said on Wednesday a study of a personalized ​mRNA vaccine combined with the immunotherapy drug Keytruda reduced ‌skin cancer recurrence and spread compared with Keytruda alone, the first positive late-stage trial results for an mRNA cancer vaccine.

(what it says) There’s a lot happening in the United States right now. A global pandemic ravages our population, mass demonstrations against police brutality and misconduct have raging for we…

NPR has learned that the Department of Health and Human Services will not be finalizing its most aggressive attempt to end gender-affirming care for youth nationally.